Hyundai Bioscience

048410.KQ

7.74 USD

-0.14

-1.78%

Overview

Last close

7.74 usd

Market cap

371.46M usd

52 week high

27.33 usd

52 week low

7.74 usd

Target price

N/A usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

36.2139

Price/Book Value

13.8195

Enterprise Value

386.40M usd

EV/Revenue

37.7379

EV/EBITDA

-64.6317

Key financials

Revenue TTM

10.24M usd

Gross Profit TTM

8.02M usd

EBITDA TTM

969331.33 usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

45.93M usd

Net debt

15.05M usd

About

Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.